
Silo Pharma, Inc.
SILOHealthcare|Biotechnology|US
$1.33
+0.04 (+3.10%)
DCF Value
$6.57
Tangible Book / Share
$4.26
Cash / Share
$4.95
Next Earnings Report
Dec 2, 2026
EPS est. -$4.80 · Revenue est. $18.0K
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Aug 6, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Silo Pharma's QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility
Sep 30, 2026 · GlobeNewsWire
Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio
Sep 18, 2026 · GlobeNewsWire
Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
Sep 9, 2026 · GlobeNewsWire
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
Aug 18, 2026 · GlobeNewsWire
SEC Filings (77)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | 8-K | Material event | DocumentIndex |
| Oct 14, 2026 | 8-K | Material event | DocumentIndex |
| Oct 2, 2026 | 8-K | Material event | DocumentIndex |
| Aug 19, 2026 | 8-K | Material event | DocumentIndex |
| Aug 17, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 6, 2026 | EFFECT | DocumentIndex | |
| Aug 6, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jul 31, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jul 24, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jul 14, 2026 | D | DocumentIndex | |
| Jul 13, 2026 | 8-K | Material event | DocumentIndex |
| Jul 8, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jun 30, 2026 | ARS | Annual report to holders | DocumentIndex |
| Jun 30, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jun 30, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 18, 2026 | 8-K | Material event | DocumentIndex |
| Jun 18, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 3, 2026 | 8-K | Material event | DocumentIndex |
| Jun 1, 2026 | 8-K | Material event | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 16, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Apr 15, 2026 | EFFECT | DocumentIndex | |
| Apr 14, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Apr 14, 2026 | POS AM | DocumentIndex | |
| Apr 13, 2026 | EFFECT | DocumentIndex | |
| Apr 10, 2026 | POS AM | DocumentIndex | |
| Apr 2, 2026 | 8-K | Material event | DocumentIndex |
| Mar 27, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 23, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Dec 29, 2025 | 8-K | Material event | DocumentIndex |
| Nov 26, 2025 | EFFECT | DocumentIndex | |
| Nov 26, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Nov 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 7, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |